News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Elsevier, Inc. / MEDai Names Dr. Peter Edelstein as Chief Medical Officer and Dr. Gerald Osband as Director of Product Strategy


8/21/2012 10:33:27 AM

ORLANDO, Florida, August 20, 2012 /PRNewswire/ --

Physician Executives Bring More Than 35 Years of Clinical and Business Experience

Elsevier / MEDai, which empowers payers and providers to transform care delivery and streamline operations through actionable analytics, announced today the appointment of two key clinicians to its leadership team. Peter Edelstein, M.D., has been appointed Chief Medical Officer, and Gerald Osband, M.D., has been appointed Director, Product Strategy.

"Peter and Jerry bring vast clinical and business experience to the company during an important time in healthcare as payers and providers are relying more on analytics to drive critical decisions," said Thomas Zajac, President of Elsevier/MEDai. "Having spent their careers working in healthcare, their insight and expertise will significantly elevate our ability to deliver actionable, personalized and predictive analytic solutions."

Dr. Edelstein brings a wealth of knowledge to the organization, including 17 years in the clinical arena and healthcare industry. With board certifications from both the American College of Surgeons and the American Society of Colon and Rectal Surgery, Dr. Edelstein was in private practice before serving on the Surgical Faculty at Stanford University, focusing on gastrointestinal, oncologic, and trauma surgery. He then spent more than a decade as an executive in the Silicon Valley medical device industry. Before joining Elsevier/MEDai, Dr. Edelstein most recently served as a physician executive within the Adventist Health System.

"The need for healthcare systems to find industry partners who provide not only scientifically sound predictive analytics tools, but who also appreciate and can address the challenges of value based purchasing and other healthcare reform initiatives is greater than ever," Dr. Edelstein said. "Elsevier/MEDai is such a company, and I'm excited to now be a part of the MEDai team."

Dr. Osband is a seasoned clinician and physician executive whose senior level positions include Chief Medical Officer and Chief Operations Officer for nationally recognized healthcare management and technology organizations. He has provided independent consulting services for several major TPAs and a data management and guidelines organization. His clinical experience is the result of 18 years of family medicine practice, including positions teaching family medicine residents and nurse practitioners. Dr. Osband has a broad background and demonstrated leadership in indemnity and managed care programs for group health, workers compensation and disability products inclusive of clinical, operational, quality, and sales responsibilities. His extensive experience in providing clinical and administrative guidance to software application development for care management, core administration, value-based incentives and value-based reimbursement products for commercial, Medicare and Medicaid programs will be invaluable to MEDai clients.

"Having worked previously with one of the companies MEDai works with, I am pleased to join the MEDai team and contributing innovative ideas and a fresh perspective on the rapidly changing healthcare industry," Dr. Osband said. "I believe my experience and clinical perspective will help us in further developing as the predictive analytics company of choice for healthcare organizations."

For more information, please visit http://www.medai.com or call +1-800-446-3324.

About Elsevier/MEDai

Elsevier/MEDai, Inc. is a premier provider of advanced analytic solutions and innovative transformation and advisory services for payers, providers, ACOs and other healthcare entities. Utilizing our proprietary predictive analytics and clinical technologies, we transform the data stream in healthcare environments to improve care quality, reduce costs, and manage population health. We empower our customers to assess and stratify patients and populations, predict risk, identify cost drivers, forecast future health costs, and drive decisions that improve outcomes. For more information on Elsevier/MEDai, visit http://www.medai.com.

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby's Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Chris Capot
Director, Corporate Relations, Elsevier
+1-212-633-3164
c.capot@elsevier.com

SOURCE Elsevier


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES